|
CAN WE PREVENT DIABETIC NEPHROPATHY?
|
Friday, February 20, 2004
|
|
7:30 AM |
CONTINENTAL BREAKFAST |
|
7:50 AM |
Announcements/Introductions
|
|
8:00 -9:00 AM |
Keynote Speaker:
Can Early BP Intervention Prevent Diabetic
Nephropathy? |
|
9:00 - 10:00 AM |
Early Diagnosis
of Diabetic Nephropathy: New Guidelines
for Estimating GFR and Interpreting Microalbuminuria |
|
10:15 - 10:30 AM |
BREAK |
|
10:30 - 11:45 AM |
Nephrotoxicity of Proteinuria
in the Diabetic Kidney: The Renal Case
for Using ACEIs/ARBs |
|
11:45 - 1:00 PM |
LUNCHEON |
|
1:00 - 2:00 PM |
Impact of Dyslipidemia in the
Diabetic: Nephropathy & Vasculopathy
|
|
2:00 - 3:00 PM |
Impact of Glycemic Control
on Risk and Progression of Diabetic Nephropathy |
|
3:00 - 3:15 PM |
BREAK |
|
3:15 - 4:15 PM |
Initiating Insulin Therapy:
When and How? |
|
|
OPTIONAL: Faculty Will Be Available for Informal Questions/Discussion |
Division
of Nephrology and Hypertension, OHSU
Division of Endocrinology, Diabetes &
Clinical Nutrition, OHSU
National
Kidney Foundation of Oregon and Southwest
Washington
CONTINUTING EDUCATION
CREDIT
Application has been made for continuing education
credits for MDs, PAs, NPs, and RNs.
Accreditation:
Oregon Health & Science University School
of Medicine is accredited by the Accreditation
Council for Continuing Medical Education to
sponsor continuing medical education for physicians.
Credit
American Medical Association: OHSU School
of Medicine, Division of CME, designates this
educational activity for a maximum of 6.5
category 1 credits toward the AMA Physician's
Recognition Award. Each physician should claim
only those credits that he/she actually earned
in the activity.
Nursing CE:
The Oregon Health & Science University
School of Nursing has approved this continuing
education activity for 8.40 credit hours.
The provider is approved by the California
Board of Registered Nursing, Provider number
CEP 5464.
FOR MORE INFORMATION
Call (503) 494-7159 or email:
REGISTRATION
Download registation form (PDF).
CANCELLATIONS
Should conditions warrant, the sponsors reserve
the right to cancel this program with a full
refund.
FUNDING
Partially funded by unrestricted educational
grants from Amgen, AstraZeneca, Merck, Novartis
and Pfizer
|
|
|